Telix's new Marketing Campaign Coordinator will "Upload and manage content across websites, landing pages". The corporate Our Portfolio page is where a patient, caregiver or clinician lands after searching for Telix, and four of its links go nowhere: "Illuccix® for US patients", "Gozellix® for US patients", "Australian product information" and "Canadian product information" all point to "#". The patient sites with "Find a Location" already exist, and Pixclara, approved in September, has no link to its health professional site at all.
First action
Send the four corrected links to the Materials Review Committee today.
How to measure it
Outbound clicks to approved product sites
- Now
- –
- Target
- tracked and rising monthly
- By
- 60 days
Steps
List the links
Every product link on the portfolio and disease area pages.
Marketing Campaign Coordinator 1 day
Confirm destinations
Approved patient sites, local product information and the Pixclara health professional site.
Digital Marketing Manager 2 days
Regulatory review
Ad-Promo and Materials Review Committee sign-off on link text and destinations.
Manager, Regulatory Affairs (Ad-Promo) 1 week
Publish
Replace the "#" links and add the Pixclara link.
Marketing Campaign Coordinator 1 hour
Tag outbound links
UTM parameters to each product site.
Marketing Campaign Coordinator 1 day
Monthly link check
Crawl all Telix web properties for broken or empty links.
Marketing Operations Coordinator monthly
Why it works
With Regulatory (Ad-Promo) and the Materials Review Committee, connect each link to its approved destination: illuccix.com and gozellix.com for US patients, the approved Australian and Canadian product information, and pixclarahcp.com for Pixclara. Then check every outbound link across the corporate, health professional, patient and trial sites each month, and tag them so the team can see how many visitors move from the corporate site to product resources.
People who reach the corporate site are looking for the next step; working links send them to approved, compliant information instead of a dead end. It is a small fix with no new claims, so review should be quick.
Ready to use
ChecklistPortfolio page link fixes
[ ] Illuccix for US patients -> approved patient site [ ] Gozellix for US patients -> approved patient site [ ] Australian product information -> approved local document [ ] Canadian product information -> approved local document [ ] Pixclara -> health professional site link added [ ] Ad-Promo / MRC sign-off recorded [ ] UTM tags on every outbound product link [ ] Monthly broken-link crawl scheduled
Risks and how to handle them
Every change goes through the Materials Review Committee
Medical, legal and regulatory review before anything is published.
Country rules differ for product information
Link non-US information only where local review approves it.
Evidence
- HiringMarketing Campaign Coordinator (US remote, posted October 12, 2026): executes campaigns "across digital channels (email, web, paid media, social)", builds them in "Marketing Cloud, CRM integrations", will "Upload and manage content across websites, landing pages, and email templates" and "Support tracking implementation (UTMs, pixels, tagging)", working with the Digital Marketing Manager and Marketing Operations Coordinator; assets must be "aligned with brand guidelines and compliance requirements".Source
- Your websiteOur Portfolio page (checked twice on October 22, 2026): the links "Illuccix® for US patients", "Gozellix® for US patients", "Australian product information" and "Canadian product information" all point to "#" and go nowhere, while the health professional links work. Pixclara® has only a prescribing information PDF and no link to its health professional site. The page says Illuccix "has been approved in United States, Canada, Australia, United Kingdom, Brazil and countries in the European Union". The footer says the site is "intended for corporate communication purposes only and is not intended as promotion".Source
- Your websiteThe patient sites illuccix.com and gozellix.com exist, each with a "Find a Location" page. The Pixclara health professional site (pixclarahcp.com) is a single page with the approved indication, a press release link and reader training; the Gozellix health professional site, by contrast, has Coding, Medical Billing Resources, Reliable Distribution and Receive Updates pages.Source
- HiringMedical and regulatory hiring: Associate Medical Directors for Prostate and for Renal Cancer Theranostics (October 15) covering launch readiness and medical education; a Medical Science Liaison, Neuro; and a Manager, Regulatory Affairs (Ad-Promo) (September 28) who reviews "advertising and promotion materials and disease awareness materials" for the US, Canada, Australia, the UK and Europe and sits on the Materials Review Committee.Source
- News coverageTelix news (October 2026): Q3 2026 group revenue US$245 million, up 19%, with Precision Medicine revenue of US$201 million, up 30%, "driven by both Gozellix® and Illuccix®"; FDA approval of Pixclara on September 14, 2026 and first commercial doses in Cleveland and Indianapolis, supplied through the distribution partner PharmaLogic; the BiPASS Phase 3 study completed enrollment and received FDA Fast Track designation; a merger with ITM Isotope Technologies Munich announced September 21, 2026.Source